特集: 調査項目の変更・追加が可能なセミカスタムオーダー型の調査レポート(Lucintel社)はこちら

特集 : 国別の市場調査レポートをお探しの方はこちら

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心調律管理 (CRM) の欧州市場:分析・規模・動向

Cardiac Rhythm Management Market Analysis, Size, Trends | Europe | MedSuite

発行 iData Research Inc. 商品コード 918705
出版日 ページ情報 英文 796 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.13円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

心調律管理 (CRM) の欧州市場:分析・規模・動向 Cardiac Rhythm Management Market Analysis, Size, Trends | Europe | MedSuite
出版日: 2019年10月03日 ページ情報: 英文 796 Pages
概要

当レポートでは、欧州の心調律管理 (CRM) 市場について調査分析し、疾患の概要、市場分析と予測、国別予測、製品ポートフォリオなどについて、体系的な情報を提供しています。

エグゼクティブサマリー

欧州の心調律管理 (CRM) ・電気生理学 (EP) ・心臓アブレーション市場の概要

競合分析

市場動向

市場の発展

処置件数

対象市場

主な調査アップデート

バージョン履歴

第1章 調査手法

第2章 疾患の概要

  • イントロダクション
  • 不整脈のタイプ
  • 心不全
  • 心停止
  • 患者人口統計

第3章 製品の評価

  • イントロダクション
  • 製品ポートフォリオ
    • ペースメーカー
    • 植込み型除細動器 (ICD)
    • 心臓再同期療法 (CRT) 装置
    • 心臓リード
    • 体外除細動器
    • ラボシステム
    • 診断用電気生理学 (EP) カテーテル
    • 心臓アブレーションカテーテル
  • 規制問題とリコール
  • 治験

第4章 欧州の心調律管理 (CRM) ・電気生理学 (EP) ・心臓アブレーション市場の概要

  • イントロダクション
  • 通貨為替レート
  • 市場概要
  • 動向分析:セグメント別
  • 促進要因・抑制要因
  • 競合市場シェア分析
  • M&A
  • 企業プロファイル
  • SWOT分析

第5章 国別プロファイル

  • イントロダクション
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン

第6章 処置件数

  • イントロダクション
  • 処置

第7章 ペースメーカー市場

  • イントロダクション
  • 市場概要
  • 市場分析・予測
  • 価格分析
  • 促進要因・抑制要因
  • 競合市場シェア分析

第8章 植込み型除細動器 (ICD) 市場

第9章 心臓再同期療法 (CRT) 装置市場

第10章 心臓リード市場

第11章 ラボシステム市場

第12章 診断用電気生理学 (EP) カテーテル市場

第13章 心臓アブレーションカテーテル市場

図表

LIST OF CHARTS

  • Chart 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe, 2015 - 2025 3
  • Chart 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, Europe, 2018 & 2025 3
  • Chart 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe, 2015 - 2025 150
  • Chart 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Europe, 2018 151
  • Chart 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, Europe, 2025 152
  • Chart 4 4: Growth Rates by Segment, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Europe, 2016 - 2025 156
  • Chart 4 5: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Europe, 2018 165
  • Chart 5 1: Country Profile, Germany, 2018 190
  • Chart 5 2: Country Profile, France, 2018 191
  • Chart 5 3: Country Profile, United Kingdom, 2018 192
  • Chart 5 4: Country Profile, Italy, 2018 193
  • Chart 5 5: Country Profile, Spain, 2018 194
  • Chart 6 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, Europe, 2015 - 2025 198
  • Chart 7 1: Pacemaker Market by Segment, Europe, 2015 - 2025 204
  • Chart 7 2: Pacemaker Market Breakdown, Europe, 2018 205
  • Chart 7 3: Pacemaker Market Breakdown, Europe, 2025 206
  • Chart 7 4: Total Pacemaker Market, Europe, 2015 - 2025 208
  • Chart 7 5: Single-Chamber Pacemaker Market by Segment, Europe, 2015 - 2025 217
  • Chart 7 6: Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 219
  • Chart 7 7: Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 226
  • Chart 7 8: Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 233
  • Chart 7 9: Dual-Chamber Pacemaker Market by Segment, Europe, 2015 - 2025 242
  • Chart 7 10: Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 244
  • Chart 7 11: Initial Placement Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 251
  • Chart 7 12: Replacement Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 258
  • Chart 7 13: Leadless Pacemaker Market, Europe, 2015 - 2025 266
  • Chart 7 14: Leading Competitors, Pacemaker Market, Europe, 2018 279
  • Chart 8 1: ICD Market by Segment, Europe, 2015 - 2025 287
  • Chart 8 2: ICD Market Breakdown, Europe, 2018 288
  • Chart 8 3: ICD Market Breakdown, Europe, 2025 289
  • Chart 8 4: Total ICD Market, Europe, 2015 - 2025 291
  • Chart 8 5: Single-Chamber ICD Market by Segment, Europe, 2015 - 2025 300
  • Chart 8 6: Total Single-Chamber ICD Market, Europe, 2015 - 2025 302
  • Chart 8 7: Initial Placement Single-Chamber ICD Market, Europe, 2015 - 2025 309
  • Chart 8 8: Replacement Single-Chamber ICD Market, Europe, 2015 - 2025 316
  • Chart 8 9: Dual-Chamber ICD Market by Segment, Europe, 2015 - 2025 325
  • Chart 8 10: Total Dual-Chamber ICD Market, Europe, 2015 - 2025 327
  • Chart 8 11: Initial Placement Dual-Chamber ICD Market, Europe, 2015 - 2025 334
  • Chart 8 12: Replacement Dual-Chamber ICD Market, Europe, 2015 - 2025 341
  • Chart 8 13: Total S-ICD Market, Europe, 2015 - 2025 349
  • Chart 8 14: Leading Competitors, ICD Market, Europe, 2018 361
  • Chart 9 1: CRT Market by Segment, Europe, 2015 - 2025 367
  • Chart 9 2: CRT Market Breakdown, Europe, 2018 368
  • Chart 9 3: CRT Market Breakdown, Europe, 2025 369
  • Chart 9 4: Total CRT Market, Europe, 2015 - 2025 371
  • Chart 9 5: CRT-P Market by Segment, Europe, 2015 - 2025 379
  • Chart 9 6: Total CRT-P Market, Europe, 2015 - 2025 381
  • Chart 9 7: Initial Placement CRT-P Market, Europe, 2015 - 2025 388
  • Chart 9 8: Replacement CRT-P Market, Europe, 2015 - 2025 395
  • Chart 9 9: CRT-D Market by Segment, Europe, 2015 - 2025 403
  • Chart 9 10: Total CRT-D Market, Europe, 2015 - 2025 405
  • Chart 9 11: Initial Placement CRT-D Market, Europe, 2015 - 2025 412
  • Chart 9 12: Replacement CRT-D Market, Europe, 2015 - 2025 419
  • Chart 9 13: Leading Competitors, CRT Market, Europe, 2018 432
  • Chart 10 1: Cardiac Leads Market by Segment, Europe, 2015 - 2025 439
  • Chart 10 2: Cardiac Leads Market Breakdown, Europe, 2018 440
  • Chart 10 3: Cardiac Leads Market Breakdown, Europe, 2025 441
  • Chart 10 4: Total Cardiac Leads Market, Europe, 2015 - 2025 443
  • Chart 10 5: Pacing Lead Market, Europe, 2015 - 2025 450
  • Chart 10 6: Defibrillation Lead Market, Europe, 2015 - 2025 457
  • Chart 10 7: LV Lead Market, Europe, 2015 - 2025 464
  • Chart 10 8: Leading Competitors, Cardiac Leads Market, Europe, 2018 476
  • Chart 11 1: Lab Systems Market by Segment, Europe, 2015 - 2025 485
  • Chart 11 2: Lab Systems Market Breakdown, Europe, 2018 486
  • Chart 11 3: Lab Systems Market Breakdown, Europe, 2025 487
  • Chart 11 4: 3D Mapping Market, Europe, 2015 - 2025 489
  • Chart 11 5: EP Recording Market, Europe, 2015 - 2025 496
  • Chart 11 6: RF Ablation Generator Market, Europe, 2015 - 2025 503
  • Chart 11 7: Remote Steering System Market, Europe, 2015 - 2025 510
  • Chart 11 8: Leading Competitors, Lab Systems Market, Europe, 2018 522
  • Chart 12 1: Diagnostic Electrophysiology Catheter Market by Segment, Europe, 2015 - 2025 527
  • Chart 12 2: Diagnostic Electrophysiology Catheter Market Breakdown, Europe, 2018 528
  • Chart 12 3: Diagnostic Electrophysiology Catheter Market Breakdown, Europe, 2025 529
  • Chart 12 4: Total Diagnostic Electrophysiology Catheter Market, Europe, 2015 - 2025 532
  • Chart 12 5: EP Conventional Catheter Market by Segment, Europe, 2015 - 2025 540
  • Chart 12 6: Total EP Conventional Catheter Market, Europe, 2015 - 2025 542
  • Chart 12 7: Fixed EP Catheter Market, Europe, 2015 - 2025 549
  • Chart 12 8: Steerable EP Catheter Market, Europe, 2015 - 2025 556
  • Chart 12 9: EP Advanced Catheter Market, Europe, 2015 - 2025 563
  • Chart 12 10: ICE Diagnostic System Market, Europe, 2015 - 2025 571
  • Chart 12 11: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Europe, 2018 584
  • Chart 13 1: Cardiac Ablation Catheter Market by Segment, Europe, 2015 - 2025 589
  • Chart 13 2: Cardiac Ablation Catheter Market Breakdown, Europe, 2018 590
  • Chart 13 3: Cardiac Ablation Catheter Market Breakdown, Europe, 2025 591
  • Chart 13 4: Total Cardiac Ablation Catheter Market, Europe, 2015 - 2025 593
  • Chart 13 5: RF Ablation Catheter Market by Segment, Europe, 2015 - 2025 602
  • Chart 13 6: Total RF Ablation Catheter Market, Europe, 2015 - 2025 604
  • Chart 13 7: Irrigated RF Ablation Catheter Market, Europe, 2015 - 2025 611
  • Chart 13 8: Non-Irrigated RF Ablation Catheter Market, Europe, 2015 - 2025 618
  • Chart 13 9: Cryoablation Catheter Market, Europe, 2015 - 2025 625
  • Chart 13 10: Leading Competitors, Cardiac Ablation Catheter Market, Europe, 2018 636
  • Chart 14 1: ICE Generator Market, Europe, 2015 - 2025 640
  • Chart 14 2: Leading Competitors, ICE Generator Market, Europe, 2018 651
  • Chart 15 1: Cryoablation Generator Market, Europe, 2015 - 2025 654
  • Chart 16 1: Electrocardiography Monitoring Market by Segment, Europe, 2015 - 2025 668
  • Chart 16 2: Electrocardiography Monitoring Market Breakdown, Europe, 2018 669
  • Chart 16 3: Electrocardiography Monitoring Market Breakdown, Europe, 2025 670
  • Chart 16 4: Resting ECG Device Market by Segment, Europe, 2015 - 2025 673
  • Chart 16 5: Total Resting ECG Device Market, Europe, 2015 - 2025 675
  • Chart 16 6: Hospital-Based Resting ECG Device Market, Europe, 2015 - 2025 682
  • Chart 16 7: Office-Based Resting ECG Device Market, Europe, 2015 - 2025 689
  • Chart 16 8: Stress Testing Device Market by Segment, Europe, 2015 - 2025 698
  • Chart 16 9: Total Stress Testing Device Market, Europe, 2015 - 2025 700
  • Chart 16 10: Hospital-Based Stress Testing Device Market, Europe, 2015 - 2025 707
  • Chart 16 11: Office-Based Stress Testing Device Market, Europe, 2015 - 2025 714
  • Chart 16 12: Holter Monitoring Recorder Market by Segment, Europe, 2015 - 2025 723
  • Chart 16 13: Total Holter Monitoring Recorder Market, Europe, 2015 - 2025 725
  • Chart 16 14: Hospital-Based Holter Monitoring Recorder Market, Europe, 2015 - 2025 732
  • Chart 16 15: Office-Based Holter Monitoring Recorder Market, Europe, 2015 - 2025 739
  • Chart 16 16: IDTF Holter Monitoring Recorder Market, Europe, 2015 - 2025 746
  • Chart 16 17: Leading Competitors, Electrocardiography Monitoring Market, Europe, 2018 759
  • Chart 17 1: External Defibrillator Market by Segment, Europe, 2015 - 2025 764
  • Chart 17 2: External Defibrillator Market Breakdown, Europe, 2018 765
  • Chart 17 3: External Defibrillator Market Breakdown, Europe, 2025 766
  • Chart 17 4: Total External Defibrillator Market, Europe, 2015 - 2025 769
  • Chart 17 5: Automated External Defibrillator Market, Europe, 2015 - 2025 776
  • Chart 17 6: Wearable Cardioverter Defibrillator Market, Europe, 2015 - 2025 783
  • Chart 17 7: Leading Competitors, External Defibrillator Market, Europe, 2018 794

LIST OF FIGURES

  • Figure 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Europe, 2018 (1 of 2) 4
  • Figure 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Europe, 2018 (2 of 2) 5
  • Figure 1 3: Companies Researched in this Report 6
  • Figure 1 4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe (1 of 2) 7
  • Figure 1 5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe (2 of 2) 8
  • Figure 1 6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2019 (1 of 3) 9
  • Figure 1 7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2019 (2 of 3) 10
  • Figure 1 8: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2019 (3 of 3) 11
  • Figure 1 9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered, Europe, 2018 12
  • Figure 1 10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, Europe (1 of 2) 13
  • Figure 1 11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, Europe (2 of 2) 14
  • Figure 1 12: Key Report Updates 15
  • Figure 1 13: Version History 15
  • Figure 3 1: Pacemaker Market Products by Company 47
  • Figure 3 2: ICD Market Products by Company 49
  • Figure 3 3: CRT Device Market Products by Company 51
  • Figure 3 4: Cardiac Leads Market Products by Company 53
  • Figure 3 5: External Defibrillator Market Products by Company 55
  • Figure 3 6: Lab Systems Market Products by Company 60
  • Figure 3 7: Diagnostic EP Catheter Market Products by Company 63
  • Figure 3 8: Cardiac Ablation Catheter Products by Company (1 of 2) 67
  • Figure 3 9: Cardiac Ablation Catheter Products by Company (2 of 2) 68
  • Figure 3 10: Class 2 Device Recall Assurity 69
  • Figure 3 11: Class 2 Device Recall Zenex 69
  • Figure 3 12: Class 2 Device Recall Accent family of pacemakers 69
  • Figure 3 13: Class 1 Device Recall Fortify, Fortify Assura 70
  • Figure 3 14: Class 1 Device Recall Fortify, Unify, Assura, including Quadra 70
  • Figure 3 15: Class 2 Device Recall Ellipse 71
  • Figure 3 16: Class 2 Device Recall Allure Quadra 71
  • Figure 3 17: Class 2 Device Recall Anthem, Allure 71
  • Figure 3 18: Class 2 Device Recall Nuance 72
  • Figure 3 19: Class 1 Device Recall Optisure HV lead 72
  • Figure 3 20: Class 3 Device Recall FIRMap 60mm Catheter 72
  • Figure 3 21: Class 2 Device Recall TactiSys Quartz Pack, PN004 400 73
  • Figure 3 22: Class 2 Device Recall SMARTABLATE RF Generator System 74
  • Figure 3 23: Class 2 Device Recall ESSENTIO Pacemaker 75
  • Figure 3 24: Class 2 Device Recall PROPONENT Pacemaker 75
  • Figure 3 25: Class 2 Device Recall ACCOLADE Pacemaker 75
  • Figure 3 26: Class 2 Device Recall PROPONENT SR Pacemaker 76
  • Figure 3 27: Class 2 Device Recall PROPONENT DR Pacemaker 76
  • Figure 3 28: Class 2 Device Recall PROPONENT EL DR Pacemaker 76
  • Figure 3 29: Class 2 Device Recall PROPONENT VDD SL Pacemaker 76
  • Figure 3 30: Class 2 Device Recall PROPONENT VDD SL Pacemaker 77
  • Figure 3 31: Class 2 Device Recall ACCOLADE MRI EL DR Pacemaker 77
  • Figure 3 32: Class 2 Device Recall ACCOLADE MRI DR Pacemaker 77
  • Figure 3 33: Class 2 Device Recall ACCOLADE MRI SR Pacemaker 77
  • Figure 3 34: Class 2 Device Recall ACCOLADE EL DR Pacemaker 78
  • Figure 3 35: Class 2 Device Recall ACCOLADE DR Pacemaker 78
  • Figure 3 36: Class 2 Device Recall ACCOLADE SR Pacemaker 78
  • Figure 3 37: Class 2 Device Recall ESSENTIO MRI EL DR Pacemaker 78
  • Figure 3 38: Class 2 Device Recall ESSENTIO MRI DR Pacemaker 79
  • Figure 3 39: Class 2 Device Recall ESSENTIO MRI SR Pacemaker 79
  • Figure 3 40: Class 2 Device Recall ESSENTIO DR Pacemaker 79
  • Figure 3 41: Class 2 Device Recall ESSENTIO SR Pacemaker 79
  • Figure 3 42: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker 80
  • Figure 3 43: Class 2 Device Recall ALTRUA 2 SR Pacemaker 80
  • Figure 3 44: Class 2 Device Recall ALTRUA 2 DR Pacemaker 80
  • Figure 3 45: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers 80
  • Figure 3 46: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT) 81
  • Figure 3 47: Class 2 Device Recall RESONATE EL ICD VR 81
  • Figure 3 48: Class 2 Device Recall RESONATE EL ICD DR 81
  • Figure 3 49: Class 2 Device Recall EMBLEM SICD, Model A209 81
  • Figure 3 50: Class 2 Device Recall SQRX 1010 Pulse Generator 82
  • Figure 3 51: Class 2 Device Recall EMBLEM MRI SICD Model 219 82
  • Figure 3 52: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator 82
  • Figure 3 53: Class 2 Device Recall VISIONIST X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) 82
  • Figure 3 54: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) 83
  • Figure 3 55: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker 83
  • Figure 3 56: Class 2 Device Recall VALITUDE CRTP Pacemaker 83
  • Figure 3 57: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker 83
  • Figure 3 58: Class 2 Device Recall VISIONIST CRTP Pacemaker 84
  • Figure 3 59: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker 84
  • Figure 3 60: Class 2 Device Recall RESONATE X4 CRTD 84
  • Figure 3 61: Class 2 Device Recall MOMENTUM X4 CRTD 84
  • Figure 3 62: Class 2 Device Recall VIGILANT X4 CRTD 85
  • Figure 3 63: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly 85
  • Figure 3 64: Class 2 Device Recall Maestro 4000 Cardiac Ablation System 85
  • Figure 3 65: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System 86
  • Figure 3 66: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters 86
  • Figure 3 67: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter 86
  • Figure 3 68: Class 2 Device Recall 9131 Defibrillator Electrodes 87
  • Figure 3 69: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator 88
  • Figure 3 70: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator 88
  • Figure 3 71: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies 89
  • Figure 3 72: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies 89
  • Figure 3 73: Class 2 Device Recall Medtronic EnTrust Escudo 90
  • Figure 3 74: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD 90
  • Figure 3 75: Class 1 Device Recall Visia AF MRI VR SureScan ICD 90
  • Figure 3 76: Class 1 Device Recall Visia AF VR ICD 91
  • Figure 3 77: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD 91
  • Figure 3 78: Class 2 Device Recall Evera ICD 91
  • Figure 3 79: Class 2 Device Recall Viva ICD 92
  • Figure 3 80: Class 2 Device Recall Percepta CRTP MRI SureScan 92
  • Figure 3 81: Class 2 Device Recall Percepta Quad CRTP MRI SureScan 92
  • Figure 3 82: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD 93
  • Figure 3 83: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD 93
  • Figure 3 84: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD 94
  • Figure 3 85: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan 94
  • Figure 3 86: Class 2 Device Recall InSync III 94
  • Figure 3 87: Class 2 Device Recall Medtronic, Temporary Pacing Lead System 95
  • Figure 3 88: Class 2 Device Recall Achieve Electrical Cable 95
  • Figure 3 89: Class 2 Device Recall Medtronic CryoConsole 95
  • Figure 3 90: Class 2 Device Recall Platinium DR 1510 96
  • Figure 3 91: Class 2 Device Recall Platinium VR 1210 96
  • Figure 3 92: Class 2 Device Recall Platinium DR DF4 1540 96
  • Figure 3 93: Class 2 Device Recall Platinium VR DF4 1240 97
  • Figure 3 94: Class 2 Device Recall PARADYM 97
  • Figure 3 95: Class 2 Device Recall OVATIO 97
  • Figure 3 96: Class 2 Device Recall INTENSIA 97
  • Figure 3 97: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator 98
  • Figure 3 98: Class 2 Device Recall Platinium CRTD 1741 98
  • Figure 3 99: Class 2 Device Recall Platinium CRT DF1 1711 98
  • Figure 3 100: Class 2 Device Recall PARADYM 99
  • Figure 3 101: Class 2 Device Recall OVATIO 99
  • Figure 3 102: Class 2 Device Recall INTENSIA 99
  • Figure 3 103: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator 100
  • Figure 3 104: Class 2 Device Recall Philips HeartStart FRx AED 100
  • Figure 3 105: Class 2 Device Recall Philips HeartStart (HS1) (Onsite/Home) AED 100
  • Figure 3 106: Class 3 Device Recall XL Defibrillator 101
  • Figure 3 107: Class 2 Device Recall Philips QCPR Meter CPR feedback device 101
  • Figure 3 108: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator 101
  • Figure 3 109: Class 2 Device Recall Philips HeartStart 101
  • Figure 3 110: Class 2 Device Recall BW Lasso 2515 ANV eco Variable Diagnostic EP Catheter 102
  • Figure 3 111: Class 2 Device Recall Reprocessed LASSO NAV eco Electrophysiology Catheter 102
  • Figure 3 112: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter 102
  • Figure 3 113: Class 2 Device Recall Stryker Sustainability Solutions Reprocessed BW Lasso 2515 NAV eco Variable Diagnostic 103
  • Figure 3 114: Class 2 Device Recall Stryker Sustainability Solutions 103
  • Figure 3 115: Class 2 Device Recall Daig Livewire Steerable and Supreme Fixed Curve Diagnostic Electrophysiology Catheters 103
  • Figure 3 116: Class 2 Class 2 Device Recall OneStep CPR Complete 104
  • Figure 3 117: Class 2 Device Recall LifeVest Wearable Defibrillator 104
  • Figure 3 118: SJM Brady MRI Post Approval Study 105
  • Figure 3 119: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) 106
  • Figure 3 120: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers 106
  • Figure 3 121: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan 106
  • Figure 3 122: BIO|MASTER.Edora Family Study 107
  • Figure 3 123: China Micra Transcatheter Pacing Study 107
  • Figure 3 124: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study) 107
  • Figure 3 125: Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study 108
  • Figure 3 126: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II 108
  • Figure 3 127: Observation of ImageReady™ MR Conditional Pacing System in China 108
  • Figure 3 128: Micra Transcatheter Pacing System Continued Access Study Protocol 109
  • Figure 3 129: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT) 109
  • Figure 3 130: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF) 110
  • Figure 3 131: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 110
  • Figure 3 132: Extravascular ICD Pilot Study 110
  • Figure 3 133: Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies 111
  • Figure 3 134: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death 111
  • Figure 3 135: BIO|MASTER.Ilivia Family/Plexa 111
  • Figure 3 136: The REACT-ICD Trial (REACT-ICD) 112
  • Figure 3 137: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial 112
  • Figure 3 138: Can Cognitive Function be Improved by Cardiac Resynchronization Therapy? (COGNI-CRT) 113
  • Figure 3 139: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure - An Investigator-driven, Prospective, Parallel-group, Randomized, Open, Blinded Outcome Assessment (PROBE), Multi-center Trial Without Investigational Medical Products (Proof of Strategy Trial) 113
  • Figure 3 140: Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D 114
  • Figure 3 141: AV Optimization Delivered with Direct His Bundle Pacing, in Patients with Heart Failure, Long PR Without Left Bundle Branch Block: Randomized Multi-center Clinical Outcome Study. 114
  • Figure 3 142: Heart Failure with Preserved Ejection Fraction Treated by Cardiac Resynchronization Therapy Versus Rate Responsive Pacing: A Mechanistic Study 115
  • Figure 3 143: Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial) 115
  • Figure 3 144: Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE) 115
  • Figure 3 145: A Multicentre Randomized Control Trial Comparing Standard Cardiac Resynchronization Pacing with Triventricular Pacing 116
  • Figure 3 146: Responders and Quadripolar LV Lead in CRT 116
  • Figure 3 147: Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalization for Heart Failure (HF)" in Patients with HF and Prolonged QRS 117
  • Figure 3 148: Plexa ICD Lead Registry 117
  • Figure 3 149: AXONE -Acute: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped with DF4 Connector 118
  • Figure 3 150: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR) 118
  • Figure 3 151: Avoid Transvenous Leads in Appropriate Subjects 119
  • Figure 3 152: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy 119
  • Figure 3 153: Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted with a Quartet Left Ventricular (LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated 120
  • Figure 3 154: Attain Stability™ Quad Clinical Study 120
  • Figure 3 155: Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP)) 121
  • Figure 3 156: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation 121
  • Figure 3 157: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP) 121
  • Figure 3 158: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy 122
  • Figure 3 159: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study 122
  • Figure 3 160: Acute Extravascular Defibrillation Study 122
  • Figure 3 161: Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance 123
  • Figure 3 162: Accuracy of Instructional Diagrams for Automated External Defibrillator (AED) Pad Positioning 123
  • Figure 3 163: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) 124
  • Figure 3 164: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter 124
  • Figure 3 165: Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR) 125
  • Figure 3 166: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia 125
  • Figure 3 167: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias 126
  • Figure 3 168: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment 126
  • Figure 3 169: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development 127
  • Figure 3 170: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 127
  • Figure 3 171: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System 128
  • Figure 3 172: INtra-procedural ultraSound Imaging for DEtermination of Atrial Wall Thickness and Acute Tissue Changes During Isolation of the Pulmonary Veins 128
  • Figure 3 173: EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry 129
  • Figure 3 174: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System 129
  • Figure 3 175: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter 130
  • Figure 3 176: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia 130
  • Figure 3 177: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness 131
  • Figure 3 178: FIRE AND ICE II Trial Pilot 132
  • Figure 3 179: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR) 132
  • Figure 3 180: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation 133
  • Figure 3 181: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 133
  • Figure 3 182: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter 134
  • Figure 3 183: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 134
  • Figure 3 184: Feasibility Study for Optically Guided Radiofrequency Ablation Catheter 134
  • Figure 3 185: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial 135
  • Figure 3 186: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter 135
  • Figure 3 187: ArcticLine Feasibility Study 135
  • Figure 3 188: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation 136
  • Figure 3 189: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation 136
  • Figure 3 190: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation 137
  • Figure 3 191: CoolLoop Paroxysmal Atrial Fibrillation 137
  • Figure 3 192: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation 138
  • Figure 3 193: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter 138
  • Figure 3 194: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) 139
  • Figure 3 195: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation 139
  • Figure 3 196: Cryterion Cardiac Cryoablation System First in Man Clinical Study 140
  • Figure 3 197: STOP Persistent AF 140
  • Figure 3 198: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure 140
  • Figure 3 199: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) 141
  • Figure 3 200: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation 141
  • Figure 3 201: Laser Ablation Study for trEatment of atRial Fibrillation (LASER) 142
  • Figure 3 202: A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF) 142
  • Figure 4 1: Currency Exchange Rate, 2018 144
  • Figure 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe, 2015 - 2025 (€M) (1 of 2) 146
  • Figure 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe, 2015 - 2025 (€M) (2 of 2) 147
  • Figure 4 4: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe, 2015 - 2025 (US$M) (1 of 2) 148
  • Figure 4 5: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Europe, 2015 - 2025 (US$M) (2 of 2) 149
  • Figure 4 6: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, Europe, 2015 - 2025 (1 of 2) 154
  • Figure 4 7: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, Europe, 2015 - 2025 (2 of 2) 155
  • Figure 4 8: Drivers and Limiters, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Europe, 2018 160
  • Figure 4 9: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Europe, 2018 (1 of 2) 163
  • Figure 4 10: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Europe, 2018 (2 of 2) 164
  • Figure 4 11: SWOT Analysis, Abbott (1 of 2) 178
  • Figure 4 12: SWOT Analysis, Abbott (2 of 2) 179
  • Figure 4 13: SWOT Analysis, Biosense Webster 180
  • Figure 4 14: SWOT Analysis, Biotronik 181
  • Figure 4 15: SWOT Analysis, Boston Scientific 182
  • Figure 4 16: SWOT Analysis, Cardiac Science 183
  • Figure 4 17: SWOT Analysis, GE Healthcare 184
  • Figure 4 18: SWOT Analysis, Medtronic 185
  • Figure 4 19: SWOT Analysis, MicroPort (1 of 2) 186
  • Figure 4 20: SWOT Analysis, MicroPort (2 of 2) 187
  • Figure 4 21: SWOT Analysis, ZOLL 188
  • Figure 6 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, Europe, 2015 - 2025 (1 of 2) 196
  • Figure 6 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, Europe, 2015 - 2025 (2 of 2) 197
  • Figure 7 1: Pacemaker Market by Segment, Europe, 2015 - 2025 (€M) 203
  • Figure 7 2: Pacemaker Market by Segment, Europe, 2015 - 2025 (US$M) 203
  • Figure 7 3: Total Pacemaker Market, Europe, 2015 - 2025 207
  • Figure 7 4: Units Sold by Country, Total Pacemaker Market, Europe, 2015 - 2025 209
  • Figure 7 5: Average Selling Price by Country, Total Pacemaker Market, Europe, 2015 - 2025 (€) 210
  • Figure 7 6: Average Selling Price by Country, Total Pacemaker Market, Europe, 2015 - 2025 (US$) 211
  • Figure 7 7: Market Value by Country, Total Pacemaker Market, Europe, 2015 - 2025 (€M) 212
  • Figure 7 8: Market Value by Country, Total Pacemaker Market, Europe, 2015 - 2025 (US$M) 213
  • Figure 7 9: Single-Chamber Pacemaker Market by Segment, Europe, 2015 - 2025 (€M) 215
  • Figure 7 10: Single-Chamber Pacemaker Market by Segment, Europe, 2015 - 2025 (US$M) 216
  • Figure 7 11: Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 218
  • Figure 7 12: Units Sold by Country, Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 220
  • Figure 7 13: Average Selling Price by Country, Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (€) 221
  • Figure 7 14: Average Selling Price by Country, Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$) 222
  • Figure 7 15: Market Value by Country, Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (€M) 223
  • Figure 7 16: Market Value by Country, Total Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$M) 224
  • Figure 7 17: Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 225
  • Figure 7 18: Units Sold by Country, Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 227
  • Figure 7 19: Average Selling Price by Country, Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (€) 228
  • Figure 7 20: Average Selling Price by Country, Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$) 229
  • Figure 7 21: Market Value by Country, Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (€M) 230
  • Figure 7 22: Market Value by Country, Initial Placement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$M) 231
  • Figure 7 23: Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 232
  • Figure 7 24: Units Sold by Country, Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 234
  • Figure 7 25: Average Selling Price by Country, Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (€) 235
  • Figure 7 26: Average Selling Price by Country, Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$) 236
  • Figure 7 27: Market Value by Country, Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (€M) 237
  • Figure 7 28: Market Value by Country, Replacement Single-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$M) 238
  • Figure 7 29: Dual-Chamber Pacemaker Market by Segment, Europe, 2015 - 2025 (€M) 240
  • Figure 7 30: Dual-Chamber Pacemaker Market by Segment, Europe, 2015 - 2025 (US$M) 241
  • Figure 7 31: Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 243
  • Figure 7 32: Units Sold by Country, Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 245
  • Figure 7 33: Average Selling Price by Country, Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 (€) 246
  • Figure 7 34: Average Selling Price by Country, Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$) 247
  • Figure 7 35: Market Value by Country, Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 (€M) 248
  • Figure 7 36: Market Value by Country, Total Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 (US$M) 249
  • Figure 7 37: Initial Placement Dual-Chamber Pacemaker Market, Europe, 2015 - 2025 250
目次
Product Code: iDATA_EUCRMEP19_MS

The full report suite on the European market for cardiac rhythm management, electrophysiology and cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, electrophysiology (EP) lab systems, diagnostic EP catheters and cardiac ablation catheters.

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging global population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR of in the single-digits.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES XIII

LIST OF CHARTS XLII

EXECUTIVE SUMMARY 1

EUROPEAN CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 9

PROCEDURE NUMBERS 12

MARKETS INCLUDED 13

KEY REPORT UPDATES 15

VERSION HISTORY 15

RESEARCH METHODOLOGY 16

  • Step 1: Project Initiation & Team Selection 16
  • Step 2: Prepare Data Systems and Perform Secondary Research 19
  • Step 3: Preparation for Interviews & Questionnaire Design 21
  • Step 4: Performing Primary Research 22
  • Step 5: Research Analysis: Establishing Baseline Estimates 24
  • Step 6: Market Forecast and Analysis 25
  • Step 7: Identify Strategic Opportunities 27
  • Step 8: Final Review and Market Release 28
  • Step 9: Customer Feedback and Market Monitoring 29

DISEASE OVERVIEW 30

  • 2.1 INTRODUCTION 30
  • 2.2 TYPES OF ARRHYTHMIAS 31
    • 2.2.11 Atrial Fibrillation 31
    • 2.2.12 Bradycardia 32
    • 2.2.13 Conduction Disorders 32
      • 2.2.13.1 Bundle Branch Block 32
      • 2.2.13.2 Heart Block 33
      • 2.2.13.3 Long QT Syndrome (LQTS) 34
    • 2.2.14 Premature Contractions: PACs and PVCs 34
    • 2.2.15 Tachycardia 35
    • 2.2.16 Ventricular Fibrillation 35
    • 2.2.17 Other Rhythm Disorders 36
      • 2.2.17.1 Adams-Stokes Disease 36
      • 2.2.17.2 Atrial Flutter 36
      • 2.2.17.3 Sick Sinus syndrome 37
      • 2.2.17.4 Sinus Arrhythmia 37
      • 2.2.17.5 Wolff-Parkinson-White Syndrome (WPW) 37
    • 2.2.18 Types of Arrhythmia in Children 37
  • 2.3 HEART FAILURE 37
  • 2.4 CARDIAC ARREST 38
  • 2.5 PATIENT DEMOGRAPHICS 40
    • 2.5.11 Atrial Fibrillation 40
    • 2.5.12 Bradycardia 40
    • 2.5.13 Conduction Disorders 41
    • 2.5.14 Premature Contractions - PACs and PVCs 42
    • 2.5.15 Tachycardia 43
    • 2.5.16 Ventricular Fibrillation 43
    • 2.5.17 Other Rhythm Disorders 44

PRODUCT ASSESSMENT 45

  • 3.1 INTRODUCTION 45
  • 3.2 PRODUCT PORTFOLIOS 45
    • 3.2.1 Pacemakers 45
    • 3.2.2 Implantable Cardioverter Defibrillators (ICDs) 48
    • 3.2.3 Cardiac Resynchronization Therapy (CRT) Devices 50
    • 3.2.4 Cardiac Leads 52
    • 3.2.5 External Defibrillators 54
    • 3.2.6 Lab Systems 56
      • 3.2.6.1 Introduction 56
      • 3.2.6.2 3D Mapping Systems 56
      • 3.2.6.3 EP Recording Systems 57
      • 3.2.6.4 Remote Steering Systems 58
      • 3.2.6.5 RF Ablation Generator 58
      • 3.2.6.6 ICE Systems 58
      • 3.2.6.7 Product Matrix for Lab Systems: Core Companies 60
    • 3.2.7 Diagnostic EP Catheters 61
      • 3.2.7.1 Introduction 61
      • 3.2.7.2 Diagnostic EP Catheters 61
      • 3.2.7.3 ICE Catheters 62
    • 3.2.8 Cardiac Ablation Catheters 64
      • 3.2.8.1 Introduction 64
      • 3.2.8.2 RF Ablation Catheters 65
      • 3.2.8.3 Alternative Energy Catheters 66
      • 3.2.8.4 High Intensity Focused Ultrasound 66
  • 3.3 REGULATORY ISSUES AND RECALLS 69
    • 3.3.1 Abbott 69
      • 3.3.1.1 Pacemakers 69
      • 3.3.1.2 Implantable Cardioverter Defibrillators (ICDs) 70
      • 3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices 71
      • 3.3.1.4 Cardiac Leads 72
      • 3.3.1.5 EP Lab Devices 72
      • 3.3.1.6 Cardiac Ablation Catheter 73
    • 3.3.2 Biosense Webster 74
      • 3.3.2.1 EP Lab Devices 74
    • 3.3.3 Boston Scientific 75
      • 3.3.3.1 Pacemakers 75
      • 3.3.3.2 Implantable Cardioverter Defibrillators (ICDs) 81
      • 3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices 82
      • 3.3.3.4 Cardiac Leads 85
      • 3.3.3.5 EP Lab Devices 85
      • 3.3.3.6 RF Ablation Catheter 86
    • 3.3.4 Cardiac Science 87
      • 3.3.4.1 Automated External Defibrillator (AED) 87
    • 3.3.5 Medtronic 88
      • 3.3.5.1 Pacemakers 88
      • 3.3.5.2 Implantable Cardioverter Defibrillators (ICDs) 89
      • 3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices 92
      • 3.3.5.4 Cardiac Leads 95
      • 3.3.5.5 EP Lab Devices 95
    • 3.3.6 MicroPort 96
      • 3.3.6.1 Implantable Cardioverter Defibrillators (ICDs) 96
      • 3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices 98
    • 3.3.7 Philips Healthcare 100
      • 3.3.7.1 Automated External Defibrillator (AED) 100
    • 3.3.8 Stryker Sustainability Solutions 102
      • 3.3.8.1 Diagnostic EP Catheters 102
    • 3.3.9 ZOLL 104
      • 3.3.9.1 Automated External Defibrillator (AED) 104
      • 3.3.9.2 Wearable Cardioverter Defibrillator (WCD) 104
  • 3.4 CLINICAL TRIALS 105
    • 3.4.1 Pacemakers 105
    • 3.4.2 Implantable Cardioverter Defibrillators (ICDs) 109
    • 3.4.3 Cardiac Resynchronization Therapy (CRT) Devices 112
    • 3.4.4 Cardiac Leads 117
    • 3.4.5 External Defibrillators 123
    • 3.4.6 Lab Systems 124
      • 3.4.6.1 3D Mapping Systems 124
      • 3.4.6.2 EP Recording Systems 126
      • 3.4.6.3 RF Ablation Generators 127
      • 3.4.6.4 ICE Systems 128
    • 3.4.7 Diagnostic EP Catheters 130
      • 3.4.7.1 Diagnostic Catheter 130
    • 3.4.8 Cardiac Ablation Catheter 132
      • 3.4.8.1 RF Ablation Catheters 132
      • 3.4.8.2 Cryoablation Catheters 135
      • 3.4.8.3 Laser Ablation Catheters 141

EUROPEAN CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 143

  • 4.1 INTRODUCTION 143
  • 4.2 CURRENCY EXCHANGE RATE 144
  • 4.3 MARKET OVERVIEW 145
  • 4.4 TREND ANALYSIS BY SEGMENT 153
  • 4.5 DRIVERS AND LIMITERS 157
    • 4.5.1 Market Drivers 157
    • 4.5.2 Market Limiters 158
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 161
  • 4.7 MERGERS AND ACQUISITIONS 166
  • 4.8 COMPANY PROFILES 167
    • 4.8.1 Abbott 167
    • 4.8.2 Biosense Webster 168
    • 4.8.3 Biotronik 169
    • 4.8.4 Boston Scientific 170
    • 4.8.5 Cardiac Science 172
    • 4.8.6 GE Healthcare 173
    • 4.8.7 Medtronic 174
    • 4.8.8 MicroPort 175
    • 4.8.9 ZOLL 177
  • 4.9 SWOT ANALYSIS 178
    • 4.9.1 Abbott 178
    • 4.9.2 Biosense Webster 180
    • 4.9.3 Biotronik 181
    • 4.9.4 Boston Scientific 182
    • 4.9.5 Cardiac Science 183
    • 4.9.6 GE Healthcare 184
    • 4.9.7 Medtronic 185
    • 4.9.8 MicroPort 186
    • 4.9.9 ZOLL 188

COUNTRY PROFILES 189

  • 5.1 INTRODUCTION 189
    • 5.1.1 Population 189
    • 5.1.2 GDP Per Capita 189
    • 5.1.3 Price Index 189
  • 5.2 GERMANY 190
  • 5.3 FRANCE 191
  • 5.4 UNITED KINGDOM 192
  • 5.5 ITALY 193
  • 5.6 SPAIN 194

PROCEDURE NUMBERS 195

  • 6.1 INTRODUCTION 195
  • 6.2 PROCEDURES 196
    • 6.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures 196

PACEMAKER MARKET 199

  • 7.1 INTRODUCTION 199
    • 7.1.1 Single and Dual-Chamber Devices 199
    • 7.1.2 MRI-Compatible Pacemaker 200
    • 7.1.3 Leadless Pacemaker 200
    • 7.1.4 Initial Placement and Replacement of Pacemakers 201
  • 7.2 MARKET OVERVIEW 202
  • 7.3 MARKET ANALYSIS AND FORECAST 207
    • 7.3.1 Total Pacemaker Market 207
    • 7.3.2 Total Single-Chamber Pacemaker Market 214
      • 7.3.2.1.1 Initial Placement Single-Chamber Pacemaker Market 225
      • 7.3.2.1.2 Replacement Single-Chamber Pacemaker Market 232
    • 7.3.3 Total Dual-Chamber Pacemaker Market 239
      • 7.3.3.1.1 Initial Placement Dual-Chamber Pacemaker Market 250
      • 7.3.3.1.2 Replacement Dual-Chamber Pacemaker Market 257
    • 7.3.4 Leadless Pacemaker Market 264
  • 7.4 PRICE ANALYSIS 272
  • 7.5 DRIVERS AND LIMITERS 273
    • 7.5.1 Market Drivers 273
    • 7.5.2 Market Limiters 274
  • 7.6 COMPETITIVE MARKET SHARE ANALYSIS 276

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET 283

  • 8.1 INTRODUCTION 283
    • 8.1.1 Cardiac Resynchronization Therapy-Defibrillators 284
  • 8.2 MARKET OVERVIEW 285
  • 8.3 MARKET ANALYSIS AND FORECAST 290
    • 8.3.1 Total ICD Market 290
    • 8.3.2 Total Single-Chamber ICD Market 297
      • 8.3.2.1.1 Initial Placement Single-Chamber ICD Market 308
      • 8.3.2.1.2 Replacement Single-Chamber ICD Market 315
    • 8.3.3 Total Dual-Chamber ICD Market 322
      • 8.3.3.1.1 Initial Placement Dual-Chamber ICD Market 333
      • 8.3.3.1.2 Replacement Dual-Chamber ICD Market 340
    • 8.3.4 S-ICD Market 347
  • 8.4 DRIVERS AND LIMITERS 355
    • 8.4.1 Market Drivers 355
    • 8.4.2 Market Limiters 356
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS 358

CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET 364

  • 9.1 INTRODUCTION 364
    • 9.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 364
    • 9.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 364
  • 9.2 MARKET OVERVIEW 365
  • 9.3 MARKET ANALYSIS AND FORECAST 370
    • 9.3.1 Total CRT Market 370
    • 9.3.2 Total CRT-P Market 377
      • 9.3.2.1.1 Initial Placement CRT-P Market 387
      • 9.3.2.1.2 Replacement CRT-P Market 394
    • 9.3.3 Total CRT-D Market 401
      • 9.3.3.1.1 Initial Placement CRT-D Market 411
      • 9.3.3.1.2 Replacement CRT-D Market 418
  • 9.4 DRIVERS AND LIMITERS 425
    • 9.4.1 Market Drivers 425
    • 9.4.2 Market Limiters 426
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 429

CARDIAC LEADS MARKET 435

  • 10.1 INTRODUCTION 435
    • 10.1.1 Replacement of Leads 436
  • 10.2 MARKET OVERVIEW 437
  • 10.3 MARKET ANALYSIS AND FORECAST 442
    • 10.3.1 Total Cardiac Leads Market 442
    • 10.3.2 Pacing Lead Market 449
    • 10.3.3 Defibrillation Lead Market 456
    • 10.3.4 LV Lead Market 463
  • 10.4 DRIVERS AND LIMITERS 470
    • 10.4.1 Market Drivers 470
    • 10.4.2 Market Limiters 471
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS 473

LAB SYSTEMS MARKET 480

  • 11.1 INTRODUCTION 480
    • 11.1.1 3D Mapping Systems 480
    • 11.1.2 EP Recording Systems 481
    • 11.1.3 Remote Steering Systems 481
    • 11.1.4 RF Ablation Generator 481
    • 11.1.5 ICE System 482
  • 11.2 MARKET OVERVIEW 483
  • 11.3 MARKET ANALYSIS AND FORECAST 488
    • 11.3.1 3D Mapping Market 488
    • 11.3.2 EP Recording Market 495
    • 11.3.3 RF Ablation Generator Market 502
    • 11.3.4 Remote Steering System Market 509
  • 11.4 DRIVERS AND LIMITERS 516
    • 11.4.1 Market Drivers 516
    • 11.4.2 Market Limiters 517
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS 519

DIAGNOSTIC ELECTROPHYSIOLOGY CATHETER MARKET 523

  • 12.1 INTRODUCTION 523
    • 12.1.1 Diagnostic Electrophysiology Catheters 523
    • 12.1.2 Reprocessed Catheters 524
    • 12.1.3 Intracardiac Echocardiography 524
  • 12.2 MARKET OVERVIEW 525
  • 12.3 MARKET ANALYSIS AND FORECAST 530
    • 12.3.1 Total Diagnostic Electrophysiology Catheter Market 530
    • 12.3.2 Total EP Conventional Catheter Market 538
      • 12.3.2.1.1 Fixed EP Catheter Market 548
      • 12.3.2.1.2 Steerable EP Catheter Market 555
    • 12.3.3 EP Advanced Catheter Market 562
    • 12.3.4 ICE Diagnostic System Market 569
  • 12.4 DRIVERS AND LIMITERS 577
    • 12.4.1 Market Drivers 577
    • 12.4.2 Market Limiters 578
  • 12.5 COMPETITIVE MARKET SHARE ANALYSIS 581

CARDIAC ABLATION CATHETER MARKET 585

  • 13.1 INTRODUCTION 585
  • 13.2 MARKET OVERVIEW 587
  • 13.3 MARKET ANALYSIS AND FORECAST 592
    • 13.3.1 Total Cardiac Ablation Catheter Market 592
    • 13.3.2 Total RF Ablation Catheter Market 599
      • 13.3.2.1.1 Irrigated RF Ablation Catheter Market 610
      • 13.3.2.1.2 Non-Irrigated RF Ablation Catheter Market 617
    • 13.3.3 Cryoablation Catheter Market 624
  • 13.4 DRIVERS AND LIMITERS 631
    • 13.4.1 Market Drivers 631
    • 13.4.2 Market Limiters 632
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS 633

APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET 638

  • 14.1 INTRODUCTION 638
  • 14.2 MARKET ANALYSIS AND FORECAST 639
  • 14.3 DRIVERS AND LIMITERS 646
    • 14.3.1 Market Drivers 646
    • 14.3.2 Market Limiters 647
  • 14.4 COMPETITIVE MARKET SHARE ANALYSIS 649

APPENDIX II: CRYOABLATION GENERATOR MARKET 652

  • 15.1 INTRODUCTION 652
  • 15.2 MARKET ANALYSIS AND FORECAST 653
  • 15.3 DRIVERS AND LIMITERS 660
    • 15.3.1 Market Drivers 660
    • 15.3.2 Market Limiters 661
  • 15.4 COMPETITIVE MARKET SHARE ANALYSIS 663

APPENDIX III: ELECTROCARDIOGRAPHY MONITORING MARKET 664

  • 16.1 INTRODUCTION 664
    • 16.1.1 Holter Monitoring 665
    • 16.1.2 Stress Testing 665
  • 16.2 MARKET OVERVIEW 666
  • 16.3 MARKET ANALYSIS AND FORECAST 671
    • 16.3.1 Total Resting ECG Device Market 671
      • 16.3.1.1.1 Hospital-Based Resting ECG Device Market 681
      • 16.3.1.1.2 Office-Based Resting ECG Device Market 688
    • 16.3.2 Total Stress Testing Device Market 695
      • 16.3.2.1.1 Hospital-Based Stress Testing Device Market 706
      • 16.3.2.1.2 Office-Based Stress Testing Device Market 713
    • 16.3.3 Total Holter Monitoring Recorder Market 720
      • 16.3.3.1.1 Hospital-Based Holter Monitoring Recorder Market 731
      • 16.3.3.1.2 Office-Based Holter Monitoring Recorder Market 738
      • 16.3.3.1.3 IDTF Holter Monitoring Recorder Market 745
  • 16.4 DRIVERS AND LIMITERS 752
    • 16.4.1 Market Drivers 752
    • 16.4.2 Market Limiters 753
  • 16.5 COMPETITIVE MARKET SHARE ANALYSIS 756

APPENDIX IV: EXTERNAL DIFIBRILLATOR MARKET 760

  • 17.1 INTRODUCTION 760
    • 17.1.1 Automated External Defibrillator 760
    • 17.1.2 Wearable Cardioverter Defibrillator 760
  • 17.2 MARKET OVERVIEW 762
  • 17.3 MARKET ANALYSIS AND FORECAST 767
    • 17.3.1 Total External Defibrillator Market 767
    • 17.3.2 Automated External Defibrillator Market 775
    • 17.3.3 Wearable Cardioverter Defibrillator Market 782
  • 17.4 DRIVERS AND LIMITERS 789
    • 17.4.1 Market Drivers 789
    • 17.4.2 Market Limiters 790
  • 17.5 COMPETITIVE MARKET SHARE ANALYSIS 792

ABBREVIATIONS 795